CORBION NV (CRBN.AS) Stock Fundamental Analysis
AMS:CRBN - NL0010583399 - Common Stock
17.245 EUR
-0.04 (-0.26%)
Taking everything into account, CRBN scores 5 out of 10 in our fundamental rating. CRBN was compared to 69 industry peers in the Chemicals industry. Both the profitability and the financial health of CRBN get a neutral evaluation. Nothing too spectacular is happening here. CRBN is cheap, but on the other hand it scores bad on growth. These ratings could make CRBN a good candidate for value investing.
1. Profitability
1.1 Basic Checks
In the past year CRBN was profitable.
CRBN had a positive operating cash flow in the past year.
In the past 5 years CRBN has always been profitable.
Each year in the past 5 years CRBN had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 4.55%, CRBN is in the better half of the industry, outperforming 71.01% of the companies in the same industry.
Looking at the Return On Equity, with a value of 9.12%, CRBN is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
CRBN has a Return On Invested Capital of 9.19%. This is in the better half of the industry: CRBN outperforms 78.26% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRBN is in line with the industry average of 6.71%.
The last Return On Invested Capital (9.19%) for CRBN is above the 3 year average (6.62%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.55% | ||
| ROE | 9.12% | ||
| ROIC | 9.19% |
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
1.3 Margins
CRBN has a better Profit Margin (5.11%) than 66.67% of its industry peers.
In the last couple of years the Profit Margin of CRBN has grown nicely.
Looking at the Operating Margin, with a value of 8.68%, CRBN is in the better half of the industry, outperforming 63.77% of the companies in the same industry.
In the last couple of years the Operating Margin of CRBN has declined.
With a Gross Margin value of 26.10%, CRBN is not doing good in the industry: 62.32% of the companies in the same industry are doing better.
CRBN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.68% | ||
| PM (TTM) | 5.11% | ||
| GM | 26.1% |
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
2. Health
2.1 Basic Checks
CRBN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CRBN has been reduced compared to 1 year ago.
Compared to 5 years ago, CRBN has less shares outstanding
Compared to 1 year ago, CRBN has an improved debt to assets ratio.
2.2 Solvency
CRBN has an Altman-Z score of 2.69. This is not the best score and indicates that CRBN is in the grey zone with still only limited risk for bankruptcy at the moment.
CRBN's Altman-Z score of 2.69 is fine compared to the rest of the industry. CRBN outperforms 63.77% of its industry peers.
The Debt to FCF ratio of CRBN is 4.95, which is a neutral value as it means it would take CRBN, 4.95 years of fcf income to pay off all of its debts.
CRBN's Debt to FCF ratio of 4.95 is amongst the best of the industry. CRBN outperforms 81.16% of its industry peers.
A Debt/Equity ratio of 0.39 indicates that CRBN is not too dependend on debt financing.
The Debt to Equity ratio of CRBN (0.39) is better than 62.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 4.95 | ||
| Altman-Z | 2.69 |
ROIC/WACC1.38
WACC6.66%
2.3 Liquidity
CRBN has a Current Ratio of 1.21. This is a normal value and indicates that CRBN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CRBN (1.21) is worse than 81.16% of its industry peers.
CRBN has a Quick Ratio of 1.21. This is a bad value and indicates that CRBN is not financially healthy enough and could expect problems in meeting its short term obligations.
CRBN has a Quick ratio of 0.60. This is amonst the worse of the industry: CRBN underperforms 91.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.21 | ||
| Quick Ratio | 0.6 |
3. Growth
3.1 Past
CRBN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -68.99%.
CRBN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 49.47% yearly.
CRBN shows a small growth in Revenue. In the last year, the Revenue has grown by 2.95%.
CRBN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.70% yearly.
EPS 1Y (TTM)-68.99%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%
3.2 Future
Based on estimates for the next years, CRBN will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.70% on average per year.
CRBN is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.78% yearly.
EPS Next Y39.48%
EPS Next 2Y23.76%
EPS Next 3Y19.05%
EPS Next 5Y12.7%
Revenue Next Year-0.75%
Revenue Next 2Y1.19%
Revenue Next 3Y2.18%
Revenue Next 5Y-0.78%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 15.40, the valuation of CRBN can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of CRBN indicates a somewhat cheap valuation: CRBN is cheaper than 78.26% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.17, CRBN is valued a bit cheaper.
The Price/Forward Earnings ratio is 11.19, which indicates a very decent valuation of CRBN.
Based on the Price/Forward Earnings ratio, CRBN is valued cheaper than 85.51% of the companies in the same industry.
CRBN is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.78, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.4 | ||
| Fwd PE | 11.19 |
4.2 Price Multiples
71.01% of the companies in the same industry are more expensive than CRBN, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CRBN is valued cheaper than 91.30% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.07 | ||
| EV/EBITDA | 7.41 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CRBN may justify a higher PE ratio.
CRBN's earnings are expected to grow with 19.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.39
PEG (5Y)0.31
EPS Next 2Y23.76%
EPS Next 3Y19.05%
5. Dividend
5.1 Amount
CRBN has a Yearly Dividend Yield of 3.76%.
CRBN's Dividend Yield is a higher than the industry average which is at 3.06.
Compared to an average S&P500 Dividend Yield of 2.34, CRBN pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.76% |
5.2 History
The dividend of CRBN has a limited annual growth rate of 5.02%.
Dividend Growth(5Y)5.02%
Div Incr Years1
Div Non Decr Years5
5.3 Sustainability
CRBN pays out 56.19% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of CRBN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP56.19%
EPS Next 2Y23.76%
EPS Next 3Y19.05%
AMS:CRBN (8/29/2025, 5:29:47 PM)
17.245
-0.04 (-0.26%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners75.76%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap1.00B
Analysts72.86
Price Target23.38 (35.58%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.76% |
Yearly Dividend0.71
Dividend Growth(5Y)5.02%
DP56.19%
Div Incr Years1
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.25%
PT rev (3m)-10.35%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-10.24%
EPS NY rev (3m)-10.24%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.36%
Revenue NY rev (3m)-2.36%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.4 | ||
| Fwd PE | 11.19 | ||
| P/S | 0.77 | ||
| P/FCF | 10.07 | ||
| P/OCF | 5.96 | ||
| P/B | 1.38 | ||
| P/tB | 1.58 | ||
| EV/EBITDA | 7.41 |
EPS(TTM)1.12
EY6.49%
EPS(NY)1.54
Fwd EY8.94%
FCF(TTM)1.71
FCFY9.94%
OCF(TTM)2.89
OCFY16.77%
SpS22.26
BVpS12.47
TBVpS10.88
PEG (NY)0.39
PEG (5Y)0.31
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.55% | ||
| ROE | 9.12% | ||
| ROCE | 10.92% | ||
| ROIC | 9.19% | ||
| ROICexc | 9.57% | ||
| ROICexgc | 10.55% | ||
| OM | 8.68% | ||
| PM (TTM) | 5.11% | ||
| GM | 26.1% | ||
| FCFM | 7.7% |
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
ROICexc(3y)7.16%
ROICexc(5y)7.83%
ROICexgc(3y)8.31%
ROICexgc(5y)9.44%
ROCE(3y)7.87%
ROCE(5y)8.47%
ROICexcg growth 3Y0.82%
ROICexcg growth 5Y-11.84%
ROICexc growth 3Y3.78%
ROICexc growth 5Y-8.06%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
F-Score6
Asset Turnover0.89
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 4.95 | ||
| Debt/EBITDA | 1.43 | ||
| Cap/Depr | 81.01% | ||
| Cap/Sales | 5.3% | ||
| Interest Coverage | 7.03 | ||
| Cash Conversion | 85.4% | ||
| Profit Quality | 150.76% | ||
| Current Ratio | 1.21 | ||
| Quick Ratio | 0.6 | ||
| Altman-Z | 2.69 |
F-Score6
WACC6.66%
ROIC/WACC1.38
Cap/Depr(3y)194.04%
Cap/Depr(5y)192.31%
Cap/Sales(3y)11.51%
Cap/Sales(5y)11.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.99%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
EPS Next Y39.48%
EPS Next 2Y23.76%
EPS Next 3Y19.05%
EPS Next 5Y12.7%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%
Revenue Next Year-0.75%
Revenue Next 2Y1.19%
Revenue Next 3Y2.18%
Revenue Next 5Y-0.78%
EBIT growth 1Y54.53%
EBIT growth 3Y8.15%
EBIT growth 5Y1.31%
EBIT Next Year139.88%
EBIT Next 3Y39.25%
EBIT Next 5Y20.83%
FCF growth 1Y171.85%
FCF growth 3YN/A
FCF growth 5Y21.2%
OCF growth 1Y118.83%
OCF growth 3Y101.81%
OCF growth 5Y9.98%